 Bifeng Gao
Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Alveoli | 3 | 2014 | 376 | 0.260 |
Why?
| | Superoxide Dismutase | 1 | 2003 | 332 | 0.180 |
Why?
| | Recombinant Fusion Proteins | 1 | 2003 | 616 | 0.170 |
Why?
| | Pneumonia | 1 | 2003 | 576 | 0.140 |
Why?
| | Immunity, Innate | 3 | 2012 | 731 | 0.140 |
Why?
| | Myoblasts | 1 | 2017 | 74 | 0.130 |
Why?
| | Epithelial Cells | 2 | 2014 | 961 | 0.130 |
Why?
| | Cell Division | 1 | 2017 | 759 | 0.120 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2010 | 1147 | 0.120 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2014 | 68 | 0.120 |
Why?
| | Chromosomal Instability | 1 | 2013 | 19 | 0.110 |
Why?
| | Microarray Analysis | 1 | 2013 | 119 | 0.110 |
Why?
| | Cell Hypoxia | 1 | 2014 | 220 | 0.110 |
Why?
| | Lung Neoplasms | 3 | 2013 | 2207 | 0.110 |
Why?
| | Glycoproteins | 1 | 2014 | 309 | 0.100 |
Why?
| | Precancerous Conditions | 1 | 2013 | 156 | 0.100 |
Why?
| | Fetal Growth Retardation | 1 | 2017 | 466 | 0.100 |
Why?
| | Oxidative Stress | 2 | 2011 | 1093 | 0.100 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2011 | 73 | 0.090 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 139 | 0.090 |
Why?
| | Influenza A virus | 1 | 2011 | 91 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2017 | 2194 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 930 | 0.080 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 577 | 0.080 |
Why?
| | Smoke | 1 | 2009 | 133 | 0.080 |
Why?
| | Down-Regulation | 1 | 2010 | 601 | 0.080 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2007 | 28 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 350 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 1447 | 0.070 |
Why?
| | Blood Platelets | 1 | 2010 | 350 | 0.070 |
Why?
| | Diet, Reducing | 1 | 2007 | 79 | 0.070 |
Why?
| | Genome-Wide Association Study | 1 | 2013 | 1218 | 0.070 |
Why?
| | Breast | 1 | 2007 | 138 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 3 | 2014 | 2262 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2353 | 0.070 |
Why?
| | Caenorhabditis elegans | 1 | 2009 | 271 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 1919 | 0.070 |
Why?
| | Influenza, Human | 1 | 2012 | 548 | 0.070 |
Why?
| | Gene Expression Profiling | 2 | 2010 | 1537 | 0.070 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 963 | 0.060 |
Why?
| | RNA, Viral | 1 | 2009 | 565 | 0.060 |
Why?
| | Macrophages | 1 | 2012 | 1284 | 0.060 |
Why?
| | Herpesvirus 3, Human | 1 | 2009 | 381 | 0.060 |
Why?
| | Rats | 3 | 2014 | 5033 | 0.060 |
Why?
| | Carrageenan | 1 | 2003 | 6 | 0.050 |
Why?
| | Edema | 1 | 2003 | 119 | 0.050 |
Why?
| | Extremities | 1 | 2003 | 113 | 0.050 |
Why?
| | Plasmids | 1 | 2003 | 345 | 0.050 |
Why?
| | Testis | 1 | 2002 | 134 | 0.050 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2003 | 274 | 0.050 |
Why?
| | Heparin | 1 | 2003 | 227 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2009 | 2574 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2002 | 223 | 0.050 |
Why?
| | Chemokines | 2 | 2012 | 214 | 0.040 |
Why?
| | Animals | 6 | 2017 | 32104 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 795 | 0.040 |
Why?
| | Base Sequence | 1 | 2003 | 2114 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2003 | 971 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2003 | 2790 | 0.040 |
Why?
| | Neutrophils | 1 | 2003 | 1172 | 0.040 |
Why?
| | Biomarkers, Tumor | 1 | 2002 | 1048 | 0.030 |
Why?
| | Cell Line | 2 | 2013 | 2651 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 746 | 0.030 |
Why?
| | Cluster Analysis | 2 | 2010 | 465 | 0.030 |
Why?
| | Sheep | 1 | 2017 | 765 | 0.030 |
Why?
| | Fetal Development | 1 | 2017 | 247 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 2013 | 41 | 0.030 |
Why?
| | Chromosome Aberrations | 1 | 2013 | 134 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2003 | 3580 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 1870 | 0.030 |
Why?
| | Lectins, C-Type | 1 | 2012 | 61 | 0.030 |
Why?
| | Drugs, Chinese Herbal | 1 | 2011 | 13 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 820 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 317 | 0.020 |
Why?
| | Humans | 8 | 2013 | 115741 | 0.020 |
Why?
| | Genes, Neoplasm | 1 | 2010 | 20 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2010 | 82 | 0.020 |
Why?
| | Surface-Active Agents | 1 | 2011 | 79 | 0.020 |
Why?
| | Phagocytosis | 1 | 2012 | 355 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2010 | 178 | 0.020 |
Why?
| | Demography | 1 | 2010 | 261 | 0.020 |
Why?
| | Exons | 1 | 2010 | 300 | 0.020 |
Why?
| | Electrophoresis, Capillary | 1 | 2009 | 21 | 0.020 |
Why?
| | RNA Splicing | 1 | 2010 | 244 | 0.020 |
Why?
| | Cotinine | 1 | 2009 | 68 | 0.020 |
Why?
| | Male | 4 | 2014 | 56050 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2011 | 332 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1569 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 526 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2009 | 158 | 0.020 |
Why?
| | Methylnitrosourea | 1 | 2007 | 6 | 0.020 |
Why?
| | Antioxidants | 1 | 2011 | 533 | 0.020 |
Why?
| | DNA Primers | 1 | 2009 | 514 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 438 | 0.020 |
Why?
| | Carcinogens | 1 | 2007 | 105 | 0.020 |
Why?
| | Insulin | 1 | 2017 | 2082 | 0.020 |
Why?
| | Pseudomonas aeruginosa | 1 | 2009 | 301 | 0.020 |
Why?
| | Nicotine | 1 | 2009 | 266 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 3914 | 0.020 |
Why?
| | Pregnancy | 1 | 2017 | 5553 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1730 | 0.010 |
Why?
| | Cytokines | 1 | 2012 | 1853 | 0.010 |
Why?
| | Middle Aged | 3 | 2011 | 27069 | 0.010 |
Why?
| | Female | 4 | 2017 | 60018 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2011 | 1700 | 0.010 |
Why?
| | Smoking | 1 | 2011 | 1457 | 0.010 |
Why?
| | Multigene Family | 1 | 2002 | 193 | 0.010 |
Why?
| | Inflammation | 1 | 2011 | 2500 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2002 | 850 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 6423 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 4541 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1642 | 0.010 |
Why?
| | Aged | 1 | 2011 | 19294 | 0.010 |
Why?
| | Adult | 1 | 2011 | 30789 | 0.010 |
Why?
|
|
Gao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|